2011
DOI: 10.1016/j.ejca.2011.04.025
|View full text |Cite
|
Sign up to set email alerts
|

Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence

Abstract: These data indicate that low expression of LMNA is associated with an increased disease recurrence in stage II and III colon cancer patients, and suggest that these patients in particular may benefit from adjuvant chemotherapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
90
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 106 publications
(95 citation statements)
references
References 28 publications
4
90
1
Order By: Relevance
“…interestingly, lamin-A/C, a protein of the nuclear envelope, was present and upregulated in the crude membrane extract from DHa-treated cells. In stage Ⅱ and Ⅲ colon cancer patients, low expression of lamin-A/C was associated with an increased disease recurrence (30). in breast cancer, it has been shown that higher lamin-A/C expression is associated with: i) early clinical stage; ⅱ) a better clinical outcomes; and ⅲ) a better overall and disease-free survival, suggesting a significant role for nuclear and chromosomal stability in this pathology (31).…”
Section: Discussionmentioning
confidence: 99%
“…interestingly, lamin-A/C, a protein of the nuclear envelope, was present and upregulated in the crude membrane extract from DHa-treated cells. In stage Ⅱ and Ⅲ colon cancer patients, low expression of lamin-A/C was associated with an increased disease recurrence (30). in breast cancer, it has been shown that higher lamin-A/C expression is associated with: i) early clinical stage; ⅱ) a better clinical outcomes; and ⅲ) a better overall and disease-free survival, suggesting a significant role for nuclear and chromosomal stability in this pathology (31).…”
Section: Discussionmentioning
confidence: 99%
“…Prominin-1 (PROM1, also known as CD133) has been studied extensively as a marker for colon cancer-initiating cells and has prognostic value to predict patient survival (43,44). Lamin A/C (LMNA) is a nuclear envelope protein that has been described as a risk biomarker for CRC (45,46). TOP2A interacts with the b-catenin/TCF-4 nuclear complex of the Wnt signaling pathway (47) and can be targeted by chemotherapeutic drugs such as etoposide and doxorubicin.…”
Section: Discussionmentioning
confidence: 99%
“…Other work has shown that the ability of myosin-II to deform the nucleus can be a decisive factor in limiting glioma migration into brain tissue (Beadle et al, 2008;Ivkovic et al, 2012), but cancer cells in general show no universal lamina phenotype (reviewed in Foster et al, 2010). Although low levels of A-type lamin have been correlated with increased reoccurrence of colon cancers (Belt et al, 2011), A-type lamin was also found to be upregulated in certain skin and ovarian cancers (Hudson et al, 2007;Tilli et al, 2003), and higher expression of these lamin proteins has been associated with better clinical outcomes in breast cancer (Wazir et al, 2013). Our own studies of tumor expansion in mouse flank have been suggestive of an association between moderately reduced levels of A-type lamin and increased invasiveness into the surrounding tissue, but a more complex relationship between the level of A-type lamin and clinical prognosis might be explained by the tenuous balance between the effect of the lamina on nuclear deformability compared with that on cell survival.…”
Section: Mechanotransduction To the Nucleus -Downstream Of Ecm And Laminmentioning
confidence: 99%